- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00624624
Follow-up of Serum Androgen Profile After Bariatric Surgery in Men With Obesity Related Hypogonadotropic Hypogonadism
November 5, 2014 updated by: Rijnstate Hospital
The purpose of this study is to determine the natural course of the androgen profile after bariatric surgery in men with obesity related hypogonadotropic hypogonadism.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
24
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Arnhem, Netherlands, 6800 TA
- Rijnstate Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 55 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Sampling Method
Non-Probability Sample
Study Population
Men with planned bariatric surgery
Description
Inclusion Criteria:
- Male
- Age 20-55 years
- Planned bariatric procedure
- Helicobacter pylori negative or adequate HP eradication
Exclusion Criteria:
- Liver and/or kidney dysfunction
- Psychiatric disease
- Medication influencing androgen profile and/or bone metabolism
- Weight > 160 kg
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
1
Eugonadal men with "Lapband"
|
|
2
Hypogonadal men with "Lapband"
|
|
3
Eugonadal men with gastric bypass procedure
|
|
4
Hypogonadal men with gastric bypass procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: H de Boer, MD, PhD, Rijnstate Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2009
Primary Completion (Actual)
March 1, 2011
Study Completion (Actual)
March 1, 2011
Study Registration Dates
First Submitted
February 15, 2008
First Submitted That Met QC Criteria
February 25, 2008
First Posted (Estimate)
February 27, 2008
Study Record Updates
Last Update Posted (Estimate)
November 6, 2014
Last Update Submitted That Met QC Criteria
November 5, 2014
Last Verified
November 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LTC-472-120607
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypogonadism
-
Clarus Therapeutics, Inc.CompletedMale Hypogonadism | Secondary Hypogonadism | Primary HypogonadismUnited States
-
University Hospital, Strasbourg, FranceRecruitingFemale HypogonadismFrance
-
Amneal Pharmaceuticals, LLCPhase One Solutions, Inc.CompletedHypogonadotropic Hypogonadism | Primary HypogonadismUnited States
-
Endo PharmaceuticalsCompletedHypogonadotropic Hypogonadism | Hypogonadism | Hypogonadism, MaleUnited States
-
Rigshospitalet, DenmarkTerminatedHypogonadotropic Hypogonadism | Hypogonadism | Hypogonadism, MaleDenmark
-
Shanghai Jiao Tong University School of MedicineUnknownIdiopathic Hypogonadotropic Hypogonadism
-
Stephanie B. Seminara, MDRecruitingHypogonadotropic HypogonadismUnited States
-
Azurity PharmaceuticalsCBCC Global ResearchNot yet recruitingHypogonadism, MaleUnited States
-
Stephanie B. Seminara, MDEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingHypogonadotropic Hypogonadism | Hypothalamic AmenorrheaUnited States
-
Endo PharmaceuticalsCompletedHypogonadism | Secondary Hypogonadism | Primary HypogonadismUnited States